Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
A Bayer-sponsored clinical trial is recruiting to evaluate hydrotalcite for relief of acid symptoms caused by acid rebound after stopping lo…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD [Phase 2]
A Phase 2 multi-center trial evaluating Panosyl-Isomaltooligosaccharides as an adjunct to PPI therapy for gastroesophageal reflux disease, c…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare [NA]
A clinical trial is evaluating medication adherence in gastroesophageal reflux disease using the GERDCare smartphone app; recruitment is cur…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Compassionate Use of Domperidone for Refractory Gastroparesis [NA]
This clinical trial update indicates a compassionate-use study of domperidone for refractory gastroparesis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Clinical Utility of WATS3D: A 5-Year Prospective Study
This update describes a 5-year prospective study evaluating the clinical utility of WATS3D for Barrett's esophagus, with the trial currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids)
This ClinicalTrials.gov entry indicates that the Czech GERDKids study is currently recruiting to determine the prevalence of symptomatic gas…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
A completed clinical trial examining the epidemiology and risk factors for gastroesophageal reflux disease in Xiamen City.
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
-
FDA approval · 2026-03-11FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) by Wal-Mart Stores Inc, enabling the store-brand generic prot…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: External UES Band (Shaker Pressure Band) and GERD [NA]
A clinical trial evaluating the external UES Band (Shaker Pressure Band) for gastroesophageal reflux disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF [NA]
Clinical trial evaluating whether CPAP affects abnormal gastroesophageal reflux and lung inflammation in idiopathic pulmonary fibrosis; the …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks [NA]
An ongoing randomized, three-arm trial compares vonaprazan 10 mg and 20 mg with esomeprazole 40 mg for healing LA Grade B or higher reflux e…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction [NA]
This Mayo Clinic-sponsored clinical trial is recruiting to study prediction of gastroesophageal reflux disease following sleeve gastrectomy.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Observational Study on GER in Patients With Simple Obesity
An observational study evaluating gastroesophageal reflux in adults with simple obesity has completed. The study investigates GER in the con…
-
EMA approval · 2026-03-02EMA Authorised: Nexium Control (esomeprazole) — Haleon Ireland Dungarvan Limited
The EMA authorized Nexium Control, a product containing esomeprazole, for gastroesophageal reflux disease, with Haleon Ireland Dungarvan Lim…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin [Phase 1]
A Phase 1 study to assess how Linaprazan Glurate affects the pharmacokinetics of Amoxicillin. The study evaluates potential drug interaction…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Vonoprazan Test for PPI Refractory GERD [NA]
A clinical trial evaluating vonoprazan for patients with PPI-refractory gastroesophageal reflux disease (refractory GERD) and non-erosive re…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study) [NA]
A clinical trial is currently recruiting to evaluate an endoscopic anti-reflux treatment using argon plasma coagulation (AREA) in patients w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Transoral Incisionless Fundoplication Database Repository (TIF)
This entry updates the status of a clinical trial database repository for Transoral Incisionless Fundoplication (TIF). The condition involve…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. [Phase 1]
Phase 1 study evaluating pharmacokinetics, bioequivalence, and safety of two Trimedat formulations (76.95 mg orally disintegrating tablet an…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Deprescribing Inappropriate Proton Pump Inhibitors [NA]
A clinical trial update indicates that a study on deprescribing inappropriate Proton Pump Inhibitors for patients with Gastroesophageal refl…
-
FDA approval · 2026-02-12FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength, a famotidine-containing product from Kenvue Brands LLC.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Breath Testing for Small Intestinal Bacterial Overgrowth [NA]
A Mayo Clinic study is evaluating breath testing to diagnose small intestinal bacterial overgrowth; the study, focusing on patients with gas…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Mechanisms Preventing Pharyngeal Reflux [NA]
Ongoing clinical trial at Medical College of Wisconsin exploring mechanisms to prevent pharyngeal reflux in gastroesophageal reflux disease;…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU
A clinical trial assessing intravenous esomeprazole 40 mg for efficacy and safety in post-surgical ICU patients at risk of stress ulcers and…